title: Modulation of GEF-H1 induced signaling by heparanase in brain metastatic melanoma cells.
abstract: Mechanisms of brain metastatic melanoma (BMM) remain largely unknown. Understanding the modulation of signaling pathways that alter BMM cell invasion and metastasis is critical to develop new therapies for BMM. Heparanase has been widely implicated in cancer and is the dominant mammalian endoglycosidase which degrades heparan sulfate chains of proteoglycans (HSPG) including syndecans (SDCs). Recent findings also indicate that heparanase possesses non-enzymatic functions in its latent form. We hypothesized that extracellular heparanase modulates BMM cell signaling by involving SDC1/4 carboxy terminal-associated proteins and downstream targets. We digested BMM cell surface HS with human recombinant active or latent heparanase to delineate their effects on cytoskeletal dynamics and cell invasiveness. We identified the small GTPase guanine nucleotide exchange factor-H1 (GEF-H1) as a new component of a SDC signaling complex that is differentially expressed in BMM cells compared to corresponding non-metastatic counterparts. Second, knockdown of GEF-H1, SDC1, or SDC4 decreased BMM cell invasiveness and GEF-H1 modulated small GTPase activity of Rac1 and RhoA in conjunction with heparanase treatment. Third, both active and latent forms of heparanase affected Rac1 and RhoA activity; notably increasing RhoA activity. Both forms of heparanase were found to mediate the expression and subcellular localization of GEF-H1, and treatment of BMM with latent heparanase modulated SDC1/4 gene expression. Finally, treatment with exogenous heparanase downregulated BMM cell invasion. These studies indicate the relevance of heparanase signaling pathways in BMM progression, and provide insights into the molecular mechanisms regulating HSPG signaling in response to exogenous heparanase.
authors.affiliation: Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas 77030, USA.
authors.forename: Lon D
authors.initials: LD
authors.lastname: Ridgway
authors.forename: Michael D
authors.initials: MD
authors.lastname: Wetzel
authors.forename: Dario
authors.initials: D
authors.lastname: Marchetti
mesh_terms: D001932:Brain Neoplasms / Q000556:secondary*; D003599:Cytoskeleton / Q000378:metabolism; D005966:Glucuronidase / Q000494:pharmacology*; D020662:Guanine Nucleotide Exchange Factors / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D008545:Melanoma / Q000473:pathology*; D009361:Neoplasm Invasiveness; D011509:Proteoglycans / Q000378:metabolism; D064067:Rho Guanine Nucleotide Exchange Factors; D015398:Signal Transduction; D053667:Syndecans / Q000378:metabolism; D000099175:Heparanase
chemical_list: D005966:Glucuronidase; D020662:Guanine Nucleotide Exchange Factors; D011509:Proteoglycans; D064067:Rho Guanine Nucleotide Exchange Factors; D053667:Syndecans; D000099175:Heparanase; C577356:ARHGEF2 protein, human
references.citation: J Cell Biochem. 2006 Feb 1;97(2):217-25
references.pmid: 16288472
references.citation: Trends Cell Biol. 2008 May;18(5):210-9
references.pmid: 18394899
references.citation: Nat Genet. 2000 Jul;25(3):329-32
references.pmid: 10888884
references.citation: Reprod Biol Endocrinol. 2004 Jan 07;2:3
references.pmid: 14711376
references.citation: Int J Biochem Cell Biol. 2006;38(12):2018-39
references.pmid: 16901744
references.citation: PLoS One. 2008 Jun 11;3(6):e2319
references.pmid: 18545691
references.citation: J Cell Sci. 2009 Oct 1;122(Pt 19):3462-71
references.pmid: 19723805
references.citation: Clin Exp Metastasis. 2008;25(2):149-59
references.pmid: 18027090
references.citation: Trends Biochem Sci. 2009 Oct;34(10):511-9
references.pmid: 19733083
references.citation: Biochem J. 2003 Jul 15;373(Pt 2):423-35
references.pmid: 12713442
references.citation: J Biol Chem. 1998 Dec 25;273(52):34954-60
references.pmid: 9857026
references.citation: J Biol Chem. 2009 Oct 16;284(42):28704-12
references.pmid: 19696445
references.citation: Neoplasia. 2006 Jul;8(7):596-606
references.pmid: 16867222
references.citation: Dev Cell. 2007 May;12(5):699-712
references.pmid: 17488622
references.citation: Cell Signal. 2009 Nov;21(11):1548-58
references.pmid: 19427900
references.citation: Cancer Res. 2008 Dec 15;68(24):10077-85
references.pmid: 19074873
references.citation: J Clin Invest. 2001 Jul;108(2):165-7
references.pmid: 11457866
references.citation: Cancer Res. 2003 Nov 15;63(22):7733-41
references.pmid: 14633698
references.citation: Circ Res. 2005 Mar 18;96(5):488-500
references.pmid: 15774861
references.citation: Cell. 1992 Aug 7;70(3):401-10
references.pmid: 1643658
references.citation: Am J Physiol Cell Physiol. 2009 Jul;297(1):C55-65
references.pmid: 19403801
references.citation: Anticancer Res. 1991 Mar-Apr;11(2):529-35
references.pmid: 2064308
references.citation: Exp Cell Res. 2003 Jun 10;286(2):219-32
references.pmid: 12749851
references.citation: J Biol Chem. 2004 Feb 27;279(9):8047-55
references.pmid: 14630925
references.citation: Cell Cycle. 2009 May 15;8(10):1484-7
references.pmid: 19372747
references.citation: J Cell Sci. 2006 Jul 1;119(Pt 13):2837-46
references.pmid: 16787950
references.citation: Genome Biol. 2009;10(3):213
references.pmid: 19291272
references.citation: Mol Cancer Res. 2010 Feb;8(2):278-90
references.pmid: 20164500
references.citation: Cell. 2008 Oct 31;135(3):510-23
references.pmid: 18984162
references.citation: Semin Oncol. 2004 Oct;31(5):693-701
references.pmid: 15497123
references.citation: J Cell Sci. 2009 Sep 15;122(Pt 18):3203-8
references.pmid: 19726629